BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23396845)

  • 1. Context is everything for dependence receptors in colorectal cancer.
    Grady WM
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2697-8. PubMed ID: 23396845
    [No Abstract]   [Full Text] [Related]  

  • 2. Dependence receptor TrkC is a putative colon cancer tumor suppressor.
    Genevois AL; Ichim G; Coissieux MM; Lambert MP; Lavial F; Goldschneider D; Jarrosson-Wuilleme L; Lepinasse F; Gouysse G; Herceg Z; Scoazec JY; Tauszig-Delamasure S; Mehlen P
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3017-22. PubMed ID: 23341610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TrkC promotes colorectal cancer growth and metastasis.
    Kim MS; Suh KW; Hong S; Jin W
    Oncotarget; 2017 Jun; 8(25):41319-41333. PubMed ID: 28455963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TrkC binds to the bone morphogenetic protein type II receptor to suppress bone morphogenetic protein signaling.
    Jin W; Yun C; Kim HS; Kim SJ
    Cancer Res; 2007 Oct; 67(20):9869-77. PubMed ID: 17942918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of trkC mRNA in the chicken embryo from gastrulation to development of secondary brain vesicles.
    Bernd P; Li R
    Brain Res Dev Brain Res; 1999 Sep; 116(2):205-9. PubMed ID: 10521565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dependence receptor TrkC triggers mitochondria-dependent apoptosis upon Cobra-1 recruitment.
    Ichim G; Genevois AL; Ménard M; Yu LY; Coelho-Aguiar JM; Llambi F; Jarrosson-Wuilleme L; Lefebvre J; Tulasne D; Dupin E; Le Douarin N; Arumäe U; Tauszig-Delamasure S; Mehlen P
    Mol Cell; 2013 Sep; 51(5):632-46. PubMed ID: 24034695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TrkB/C-induced HOXC6 activation enhances the ADAM8-mediated metastasis of chemoresistant colon cancer cells.
    Park GB; Choi S; Yoon YS; Kim D
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of TRKC by SOX2 in human embryonic stem cells.
    Fong H; Wong RC; Donovan PJ
    Stem Cell Res; 2012 Mar; 8(2):206-14. PubMed ID: 22265740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal expression of noncatalytic TrkC NC2 isoform during early and late CNS neurogenesis: a comparative study with TrkC catalytic and p75NTR receptors.
    Menn B; Timsit S; Represa A; Mateos S; Calothy G; Lamballe F
    Eur J Neurosci; 2000 Sep; 12(9):3211-23. PubMed ID: 10998105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional deletion of TrkC does not modify limbic epileptogenesis.
    Soren Leonard A; Puranam RS; Helgager J; Liu G; McNamara JO
    Epilepsy Res; 2012 Nov; 102(1-2):126-30. PubMed ID: 22980123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of trkB.T1 and trkB.T2, truncated trkC, and p75(NGFR) in the cochlea prior to hearing function.
    Gestwa G; Wiechers B; Zimmermann U; Praetorius M; Rohbock K; Köpschall I; Zenner HP; Knipper M
    J Comp Neurol; 1999 Nov; 414(1):33-49. PubMed ID: 10494076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer.
    Luo Y; Kaz AM; Kanngurn S; Welsch P; Morris SM; Wang J; Lutterbaugh JD; Markowitz SD; Grady WM
    PLoS Genet; 2013; 9(7):e1003552. PubMed ID: 23874207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression of TrkC (NTRK3) in human soft tissue tumours.
    Hisaoka M; Sheng WQ; Tanaka A; Hashimoto H
    J Pathol; 2002 Aug; 197(5):661-7. PubMed ID: 12210087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptidomimetic of NT-3 acts as a TrkC antagonist.
    Brahimi F; Malakhov A; Lee HB; Pattarawarapan M; Ivanisevic L; Burgess K; Saragovi HU
    Peptides; 2009 Oct; 30(10):1833-9. PubMed ID: 19647025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.
    Lawn S; Krishna N; Pisklakova A; Qu X; Fenstermacher DA; Fournier M; Vrionis FD; Tran N; Chan JA; Kenchappa RS; Forsyth PA
    J Biol Chem; 2015 Feb; 290(6):3814-24. PubMed ID: 25538243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis.
    Bouzas-Rodriguez J; Cabrera JR; Delloye-Bourgeois C; Ichim G; Delcros JG; Raquin MA; Rousseau R; Combaret V; Bénard J; Tauszig-Delamasure S; Mehlen P
    J Clin Invest; 2010 Mar; 120(3):850-8. PubMed ID: 20160348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant adenovirus vector-mediated functional expression of neurotropin-3 receptor (TrkC) in neural stem cells.
    Wang JM; Zeng YS; Liu RY; Huang WL; Xiong Y; Wang YH; Chen SJ; Teng YD
    Exp Neurol; 2007 Jan; 203(1):123-7. PubMed ID: 17007838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant changes in cortical TrkC mRNA and protein during the human lifespan.
    Beltaifa S; Webster MJ; Ligons DL; Fatula RJ; Herman MM; Kleinman JE; Weickert CS
    Eur J Neurosci; 2005 May; 21(9):2433-44. PubMed ID: 15932601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase expression and TrkC/p75NTR ratios in human medulloblastoma.
    Sinnappah-Kang ND; Mrak RE; Paulsen DB; Marchetti D
    Clin Exp Metastasis; 2006; 23(1):55-63. PubMed ID: 16826429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TrkC binds to the type II TGF-beta receptor to suppress TGF-beta signaling.
    Jin W; Yun C; Kwak MK; Kim TA; Kim SJ
    Oncogene; 2007 Dec; 26(55):7684-91. PubMed ID: 17546043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.